Conference Call Scheduled for Today, August 4, 2021, at 3:30 PM CT (4:30 PM ET) Revenues of $71.0 million increased 66.8% compared to fourth quarter last year and increased 12.2% sequentially compared to third quarter this year Fiscal 2021 revenues increased 9.5% to a record high $259 million Management provides […]
Author: Ken Dropiewski
AtriCure Reports Second Quarter 2021 Financial Results
MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced second quarter 2021 financial results. “Our second quarter results were driven by outperformance across our business, as strong underlying demand returned and we saw continued progress toward making […]
Abiomed Announces Record Revenue of $253 Million, Up 53% Year Over Year
Full year global revenue guidance increased for fiscal year 2022 to 22% – 24% growth versus prior year DANVERS, Mass.–(BUSINESS WIRE)–Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced financial results for the quarter ended June 30, 2021. Q1 financial summary and operational highlights: Total […]
ARCA biopharma Announces Second Quarter 2021 Financial Results and Provides Corporate Update
Phase 2b clinical trial evaluating rNAPc2 as a potential treatment for COVID-19 expanded to South America Topline data anticipated in the fourth quarter of 2021 WESTMINSTER, Colo., Aug. 04, 2021 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for […]
Amarin Reports Second Quarter and Six Month 2021 Financial Results and Provides Business Update
Commercial Launch of VAZKEPA in Europe on Track to Commence in September in Germany Filed Several Market Access Dossiers in Europe with Proposed Pricing of approximately €200 per Month New CEO, Karim Mikhail, to Host Conference Call Today at 7:30 a.m. ET DUBLIN, Ireland and BRIDGEWATER, N.J., Aug. 05, 2021 (GLOBE NEWSWIRE) […]
CVRx Reports Second Quarter 2021 Financial and Operating Results
Second Quarter 2021 Revenue of $3.1 Million, a 150% Increase Over Prior Year MINNEAPOLIS, Aug. 04, 2021 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and minimally invasive neuromodulation solutions for patients with cardiovascular diseases, today announced its […]
Bellerophon Provides Clinical Program Update and Reports Second Quarter 2021 Financial Results
WARREN, N.J., Aug. 05, 2021 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today provided a clinical program update and reported financial results for the second quarter ended June 30, 2021. “We continue to progress […]
Madrigal Pharmaceuticals Reports 2021 Second Quarter Financial Results and Provides Corporate Update
CONSHOHOCKEN, Pa., Aug. 05, 2021 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) reports today its second quarter 2021 financial results and provides a summary of corporate accomplishments. Paul Friedman, M.D., Chief Executive Officer of Madrigal, stated, “The Madrigal team has made great progress on multiple fronts in the first half […]
EchoNous Partners with Us2.ai for Machine Learning-enabled Analysis of Heart Scans
Kosmos Platform Will Now Offer Physicians Accurate Heart Health Analysis in Minutes REDMOND, Wash.–(BUSINESS WIRE)–EchoNous, the leader in ultra-portable, AI-guided point-of-care ultrasound (POCUS) tools and software, announced that the company has partnered with Singapore-based Us2.ai, developers of machine learning-driven software that automates the analyses of echocardiographic imagery and measurements. Us2.ai’s […]
Abcentra Announces First Patients Dosed with Orticumab in Clinical Trial Evaluating Blockade of Oxidized LDL in Psoriasis with Elevated Cardiometabolic Risk
LOS ANGELES, Aug. 4, 2021 /PRNewswire/ — Today, Abcentra LLC announced that the first patients have been dosed in its multi-center phase 2 trial assessing the safety and activity of orticumab in patients with moderate-to-severe plaque psoriasis and cardiometabolic risk factors. Orticumab is a fully-human monoclonal antibody against a specific oxidized low-density lipoprotein (LDL) epitope. Seventeen […]
Recent
Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive Team will be Joined by Current Users of the LIBERTY Endovascular Robotic System, Dr. Charles Briggs and Dr. Zachary Bercu
Atrium Therapeutics Reports First Quarter 2026 Financial Results
Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance
Popular
- No commented posts yet